Summary of Significant Accounting Policies (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Summary of Significant Accounting Policies [Abstract] |
|
| Schedule of Restatement of Interim Financial Statements |
Following is the impact of the Restatement to the September 30, 2025 interim financial statements | | | September 30, 2025 | | Unaudited Condensed Consolidated Balance Sheets | | As Reported | | | Adjustments | | | As Restated | | | Due from related parties | | $ | 2,694,743 | | | $ | (760,546 | ) | | $ | 1,934,197 | | | Current Assets | | | 4,072,569 | | | | (760,546 | ) | | | 3,312,023 | | | Property and equipment, net | | | 12,055,642 | | | | 798,486 | | | | 12,854,128 | | | Total Assets | | | 21,176,299 | | | | 37,940 | | | | 21,214,239 | | | | | | | | | | | | | | | | | Due to related parties | | $ | 1,201,592 | | | $ | 35,404 | | | $ | 1,236,996 | | | Current Liabilities | | | 6,507,520 | | | | 35,404 | | | | 6,542,924 | | | Total Liabilities | | | 6,683,592 | | | | 35,404 | | | | 6,718,996 | | | Additional paid-in capital | | | 93,114,989 | | | | 798,486 | | | | 93,913,475 | | | Accumulated deficit | | | (73,295,417 | ) | | | (795,950 | ) | | | (74,091,367 | ) | | Total stockholders’ equity | | | 12,057,619 | | | | 2,536 | | | | 12,060,155 | | | Total Equity | | | 14,492,707 | | | | 2,536 | | | | 14,495,243 | | | Total Liabilities and Equity | | $ | 21,176,299 | | | $ | 37,940 | | | $ | 21,214,239 | |
|
| Schedule of Unaudited Condensed Consolidated Statements of Cash Flows |
| | | Nine Months Ended September 30, 2025 | | Unaudited Condensed Consolidated Statements of Cash Flows | | As Reported | | | Adjustments | | | As Restated | | | Net loss | | $ | (4,564,546 | ) | | $ | (795,950 | ) | | $ | (5,360,496 | ) | | Due from related parties | | | (169,796 | ) | | | (35,503 | ) | | | (205,299 | ) | | Net cash used in operating activities | | | (1,567,264 | ) | | | (831,453 | ) | | | (2,398,717 | ) | | Loan to related parties | | | (2,079,352 | ) | | | 760,000 | | | | (1,319,352 | ) | | Net cash used in investing activities | | | (1,939,136 | ) | | | 795,950 | | | | (1,179,136 | ) | | Due to related parties | | | (71,453 | ) | | | 71,453 | | | | - | | | Net cash provided by financing activities | | | 3,488,478 | | | | 71,453 | | | | 3,559,931 | | | Issuance of common stock and warrants in the land acquisition | | $ | 3,357,975 | | | $ | 798,486 | | | $ | 4,156,461 | |
|
| Schedule of Property and Equipment, Net |
Depreciation is calculated on the straight-line method generally based on the following useful lives: | | | Estimated Life in Years | | Buildings and leasehold improvements | | 5 ~ 50 | | Machinery and equipment | | 5 ~ 10 | | Vehicles | | 2 | | Office equipment | | 3 ~ 6 |
|
| Schedule of Earning Per Share |
Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive. | | | Three Months Ended | | | Nine Months Ended | | | | | | | | September 30 | | | | | | September 30 | | | | | September 30 2026 | | | 2025 (Restated) | | | September 30 2026 | | | 2025 (Restated) | | | Numerator: | | | | | | | | | | | | | | Net loss attributable to ABVC’s common stockholders | | $ | 1,149,300 | | | $ | (2,042,463 | ) | | $ | (1,147,876 | ) | | $ | (5,141,560 | ) | | | | | | | | | | | | | | | | | | | | Denominator: | | | - | | | | | | | | | | | | | | | Weighted-average shares outstanding – Basic & Diluted | | | 26,656,942 | | | | 23,256,590 | | | | 26,059,207 | | | | 18,567,480 | | | Loss per share | | | | | | | | | | | | | | | | | | -Basic & Diluted | | $ | 0.04 | | | $ | (0.09 | ) | | $ | (0.04 | ) | | $ | (0.28 | ) |
|
| Schedule of Segment Profit or Loss |
The following table presents revenue, significant segment expenses, and the reported measure of segment profit or loss for the three and nine months ended September 30, 2026 and 2025,which the CODM uses to assess segment performance and allocate resources. | | | Three Months Ended | | | Nine Months Ended | | | | | September 30, | | | September 30 | | | September 30 | | | September 30 | | | | | 2026 | | | 2025 | | | 2026 | | | 2025 | | | Revenues | | $ | - | | | $ | - | | | $ | - | | | $ | - | | | Cost of revenues | | | - | | | | - | | | | - | | | | - | | | Segment Gross (loss) profit | | | - | | | | - | | | | - | | | | - | | | | | | | | | | | | | | | | | | | | | Selling, general and administrative expenses | | | 376,946 | | | | 798,253 | | | | 1,632,722 | | | | 2,103,718 | | | Research and development expenses | | | 18,040 | | | | 29,890 | | | | 73,847 | | | | 92,027 | | | Stock-based compensation | | | 845,607 | | | | 1,136,217 | | | | 1,886,022 | | | | 2,756,603 | | | | | | | | | | | | | | | | | | | | | Loss before provision for income tax | | | (1,390,132 | ) | | | (2,082,946 | ) | | | (3,890,550 | ) | | | (5,336,342 | ) |
|